RESEARCH-USE BIOSIMILAR ANTIBODY
Ublituximab
Monoclonal antibody · IgG1
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects.
TARGETMS4A1
YMonoclonal antibody
CATALOGSC-BS-074
CATALOG NUMBERSC-BS-074
MOLECULAR WEIGHTApprox. 144.18 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects.
Ublituximab is a recombinant research-use antibody directed against MS4A1.